Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity

Chin Med J (Engl). 2016 Dec 5;129(23):2879-2881. doi: 10.4103/0366-6999.194638.

Authors

Xiu-Juan Li¹, Xiao-Peng Yang², Shuang Sun³, Xiao-Bei Lyu¹, Heng Jia¹

Affiliations

¹ Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
² Department of Medical Equipment, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
³ Department of Ophthalmology, Children's Hospital of Zhengzhou, Zhengzhou, Henan 450052, China.

No abstract available

MeSH terms

Angiogenesis Inhibitors / administration & dosage
Angiogenesis Inhibitors / therapeutic use
Female
Humans
Infant
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature
Intravitreal Injections / methods*
Ranibizumab / administration & dosage*
Ranibizumab / therapeutic use*
Retinopathy of Prematurity / drug therapy*
Retinopathy of Prematurity / surgery
Retrospective Studies

Substances

Angiogenesis Inhibitors
Ranibizumab